Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
OncoLize logo — "Treating Tumors from the Inside" - Intra-tumoral delivery o...

OncoLize

"Treating Tumors from the Inside" - Intra-tumoral delivery of oncology drugs

Founded 2017 The Netherlands The Netherlands 5 employees Seed Total: $1.70M Pharmaceutical

General Information

Company Name OncoLize
Founded Year 2017
Location The Netherlands The Netherlands
Employees 5
Industries Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with OncoLize. To contact OncoLize, visit oncolize.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does OncoLize compare?

A PDF of OncoLize and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting OncoLize soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About OncoLize

OncoLize, a pharmaceutical startup founded in 2017 in The Netherlands, has recently secured a significant $1.70M Seed Round investment at 13 April 2023 from LEH and Tailored Solutions Pvt. Ltd. The company specializes in developing injectable drug depots to treat rare and deadly tumor diseases with a focus on GBM-tumors in the brain, and plans to expand to include pancreatic, prostate, and urinary tract tumors. OncoLize's innovative approach involves localizing small drug depots inside solid tumors, allowing for the gradual release of well-known drugs at much higher concentrations than oral medication or intravenous injections. This targeted delivery method aims to provide better treatment options with fewer side-effects and lower costs in the pharmaceutical industry. With the upcoming launch of their website at the end of November, OncoLize positions itself as a promising player in the field of tumor treatment solutions.

Taxonomy: injectable drug depots, biomedical polymers, pharmaceutical hydrogels, oncology, GlioBlastoma Multiforma, drug delivery, pancreas tumors, brain tumors, tumor treatment, chemo-drugs, drug formulations

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $1.70M 2
LEH, Tailored Solutions Pvt. Ltd.
13 Apr 2023

OncoLize Alternatives & Competitors

View All Alternatives
OncoLize vs
Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. United States

Targeted Therapy Delivered

Acquired
39 employees
Biotechnology, Health and Wellness
OncoLize vs
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. United States

Power and precision in cancer radiotherapeutics.

IPO
27 employees
Pharmaceutical
OncoLize vs
Duo Oncology
Duo Oncology United States

Nanomedicines as the foundation of cancer medicine. Platform chemistry designed for patients.

Seed
4 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About OncoLize

"Treating Tumors from the Inside" - Intra-tumoral delivery of oncology drugs
OncoLize was founded in 2017.
OncoLize is headquartered in The Netherlands.
OncoLize operates in Pharmaceutical. Its work centres on injectable drug depots, biomedical polymers, pharmaceutical hydrogels and oncology.
OncoLize has approximately 5 employees.
OncoLize has completed 1 funding round, raising a total of $1.70M. The latest funding stage is Seed.
Top alternatives and competitors to OncoLize include Lisata Therapeutics, Inc., Plus Therapeutics, Inc., Duo Oncology, Starpax Biopharma, Liposeuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OncoLize and Lisata Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for OncoLize, https://bouncewatch.com/company/oncolize, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes